PET imaging of inflammation in atherosclerosis
PET imaging of atherosclerosis can quantify several in vivo pathological processes
occurring within the arterial system. 18F-fluorodeoxyglucose (FDG) is the most-commonly …
occurring within the arterial system. 18F-fluorodeoxyglucose (FDG) is the most-commonly …
Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?
S Kralisch, M Fasshauer - Diabetologia, 2013 - Springer
Adipocyte fatty acid binding protein (AFABP, also known as aP2 and FABP4) has recently
been introduced as a novel fat-derived circulating protein. AFABP serum concentrations are …
been introduced as a novel fat-derived circulating protein. AFABP serum concentrations are …
Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis
J Bucerius, F Hyafil, HJ Verberne, RHJA Slart… - European journal of …, 2016 - Springer
Cardiovascular diseases are the leading cause of death not only in Europe but also in the
rest of the World. Preventive measures, however, often fail and cardiovascular disease may …
rest of the World. Preventive measures, however, often fail and cardiovascular disease may …
Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial …
N Alexopoulos, BH Melek, CD Arepalli… - Journal of the American …, 2013 - jacc.org
Objectives: This study sought to evaluate the effect of intensive and moderate statin therapy
on epicardial adipose tissue (EAT). Background: EAT has been associated with coronary …
on epicardial adipose tissue (EAT). Background: EAT has been associated with coronary …
Noninvasive plaque imaging to accelerate coronary artery disease drug development
Coronary artery disease (CAD) remains the leading cause of adult mortality globally.
Targeting known modifiable risk factors has had substantial benefit, but there remains a …
Targeting known modifiable risk factors has had substantial benefit, but there remains a …
[HTML][HTML] TNF-α antagonist and vascular inflammation in patients with psoriasis vulgaris: a randomized placebo-controlled study
R Bissonnette, F Harel, JG Krueger, MC Guertin… - Journal of Investigative …, 2017 - Elsevier
Vascular inflammation is increased in patients with psoriasis. This randomized, double-
blind, multicenter study evaluated the effects of tumor necrosis factor-α antagonist …
blind, multicenter study evaluated the effects of tumor necrosis factor-α antagonist …
Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging: Implications for Vascular Interventional Studies
FM van der Valk, SL Verweij, KAH Zwinderman… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: This study assessed 5 frequently applied arterial 18fluorodeoxyglucose (18F-
FDG) uptake metrics in healthy control subjects, those with risk factors and patients with …
FDG) uptake metrics in healthy control subjects, those with risk factors and patients with …
Effect of statin therapy on arterial wall inflammation based on 18F-FDG PET/CT: a systematic review and meta-analysis of interventional studies
M Pirro, LE Simental-Mendía, V Bianconi… - Journal of clinical …, 2019 - mdpi.com
Aim. To evaluate by meta-analysis of interventional studies the effect of statin therapy on
arterial wall inflammation. Background. Arterial exposure to low-density lipoprotein (LDL) …
arterial wall inflammation. Background. Arterial exposure to low-density lipoprotein (LDL) …
PET imaging of atherosclerotic disease: advancing plaque assessment from anatomy to pathophysiology
Atherosclerosis is a leading cause of morbidity and mortality. It is now widely recognized that
the disease is more than simply a flow-limiting process and that the atheromatous plaque …
the disease is more than simply a flow-limiting process and that the atheromatous plaque …
[HTML][HTML] Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis
JK Jensen, T Binderup, CE Grandjean, S Bentsen… - Atherosclerosis, 2022 - Elsevier
Background and aims The objective of this study was to investigate the effects of
semaglutide, a long acting glucagon-like peptide-1 receptor agonist, on atherosclerotic …
semaglutide, a long acting glucagon-like peptide-1 receptor agonist, on atherosclerotic …